Joukje C. Wanten
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Joukje C. Wanten has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Rudy M. M. A. Nuijts
University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands
8 shared publications - Noël J. C. Bauer
University Eye Clinic Maastricht, Maastricht University Medical Centre, Maastricht, The Netherlands
7 shared publications - Frank J. H. M. van Den Biggelaar
University Eye Clinic, Maastricht University Medical Center+, Maastricht, the Netherlands
3 shared publications - Janneau L. J. Claessens
University Medical Center Utrecht
3 shared publications Rudy M.M.A. Nuijts
University Eye Clinic, Maastricht University Medical Center, the Netherlands
3 shared publicationsNoël J.C. Bauer
From the University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands
2 shared publications
Latest Publications
- Open Access
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (9) , e1-e13
ESCRS guideline for cataract surgery 2024: executive summary
Cataract is a leading cause of visual impairment globally, with surgery as the only effective treatment. Management involves a care pathway, including screening, patient selection, preoperative assessment, surgery, and postoperative care. The ESCRS developed evidence-based guidelines to aid decision-making for patients, clinicians, and stakeholders. A multidisciplinary panel, supported by methodologists using the Grading of Recommendations, Assessment, Development, and Evaluations approach, addressed 32 key clinical questions. Recommendations include intracameral antibiotics to prevent endophthalmitis, topical anesthesia as the preferred technique, and toric intraocular lenses for corneal astigmatism ≥1.0 diopter. Conventional and femtosecond laser-assisted surgeries are comparably safe and effective. Nonsteroidal anti-inflammatory drug eyedrops, alone or with corticosteroids, are recommended to reduce inflammation and prevent cystoid macular edema. Additional guidance includes shared decision-making for lens selection, safe use of immediate sequential bilateral cataract surgery, and potential of remote postoperative care to enhance healthcare efficiency. These guidelines aim to improve outcomes, patient experience, and care delivery.
- 1 September 2026
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 52 (9) , e1-e13
Open AccessESCRS guideline for cataract surgery 2024: executive summary
Cataract is a leading cause of visual impairment globally, with surgery as the only effective treatment. Management involves a care pathway, including screening, patient selection, preoperative assessment, surgery, and postoperative care. The ESCRS developed evidence-based guidelines to aid decision-making for patients, clinicians, and stakeholders. A multidisciplinary panel, supported by methodologists using the Grading of Recommendations, Assessment, Development, and Evaluations approach, addressed 32 key clinical questions. Recommendations include intracameral antibiotics to prevent endophthalmitis, topical anesthesia as the preferred technique, and toric intraocular lenses for corneal astigmatism ≥1.0 diopter. Conventional and femtosecond laser-assisted surgeries are comparably safe and effective. Nonsteroidal anti-inflammatory drug eyedrops, alone or with corticosteroids, are recommended to reduce inflammation and prevent cystoid macular edema. Additional guidance includes shared decision-making for lens selection, safe use of immediate sequential bilateral cataract surgery, and potential of remote postoperative care to enhance healthcare efficiency. These guidelines aim to improve outcomes, patient experience, and care delivery.
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (11) , 972-978
Barrett RX tool for intraocular lens power calculation in pseudophakic eyes undergoing intraocular lens exchange
Purpose: To assess the accuracy of refraction prediction after intraocular lens (IOL) exchange using a software integrated in a Scheimpflug-based biometer. Setting: 2 tertiary referral hospitals. Design: Case series. Methods: Eyes that underwent uneventful bag-to-bag IOL exchange between 2017 and 2024 and complete preoperative and postoperative measurements were included. IOL exchange was performed by 2 experienced surgeons. IOL power was calculated using the Barrett RX formula integrated in Pentacam software, incorporating both phakic and pseudophakic biometric data and subjective refraction. Prediction errors were computed by comparing actual postoperative and predicted refractions. Moreover, an unpublished estimation formula was evaluated. Results: 25 eyes of 25 patients (mean age 60.2 ± 11.4 years) were included. Mean interval between primary IOL implantation and exchange was 25.3 ± 31.5 weeks. In 11 of 25 eyes, a different IOL model was implanted during the exchange. Using the Barrett RX formula, the mean prediction error (MPE) was 0.02 ± 0.32 diopters (D), mean absolute error (MAE) 0.27 ± 0.17 D, and median absolute error (MedAE) 0.22 D. A total of 56% and 92% of eyes were within ±0.25 D and ±0.50 D of target refraction, respectively. The conventional formula yielded a comparable MPE of –0.12 ± 0.68 D ( P = .479), but higher MAE and MedAE (0.53 ± 0.42 D and 0.40 D, P < .001), with 32% and 56% of eyes within ±0.25 D and ±0.50 D, respectively. Conclusions: The Barrett RX formula was demonstrated to be an efficacious method for calculating IOL power in eyes undergoing IOL exchange, with more than half of cases within ±0.25 D of the predicted postexchange refraction.
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (11) , 972-978
Barrett RX tool for intraocular lens power calculation in pseudophakic eyes undergoing intraocular lens exchange
Purpose: To assess the accuracy of refraction prediction after intraocular lens (IOL) exchange using a software integrated in a Scheimpflug-based biometer. Setting: 2 tertiary referral hospitals. Design: Case series. Methods: Eyes that underwent uneventful bag-to-bag IOL exchange between 2017 and 2024 and complete preoperative and postoperative measurements were included. IOL exchange was performed by 2 experienced surgeons. IOL power was calculated using the Barrett RX formula integrated in Pentacam software, incorporating both phakic and pseudophakic biometric data and subjective refraction. Prediction errors were computed by comparing actual postoperative and predicted refractions. Moreover, an unpublished estimation formula was evaluated. Results: 25 eyes of 25 patients (mean age 60.2 ± 11.4 years) were included. Mean interval between primary IOL implantation and exchange was 25.3 ± 31.5 weeks. In 11 of 25 eyes, a different IOL model was implanted during the exchange. Using the Barrett RX formula, the mean prediction error (MPE) was 0.02 ± 0.32 diopters (D), mean absolute error (MAE) 0.27 ± 0.17 D, and median absolute error (MedAE) 0.22 D. A total of 56% and 92% of eyes were within ±0.25 D and ±0.50 D of target refraction, respectively. The conventional formula yielded a comparable MPE of –0.12 ± 0.68 D ( P = .479), but higher MAE and MedAE (0.53 ± 0.42 D and 0.40 D, P < .001), with 32% and 56% of eyes within ±0.25 D and ±0.50 D, respectively. Conclusions: The Barrett RX formula was demonstrated to be an efficacious method for calculating IOL power in eyes undergoing IOL exchange, with more than half of cases within ±0.25 D of the predicted postexchange refraction.
- Open Access
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (11) , 963-971
Six-month performance and safety of an iris-fixated multifocal intraocular lens for presbyopia correction in phakic eyes
Purpose: To evaluate the 6-month effectiveness and safety of a new foldable multifocal iris-fixated phakic intraocular lens (pIOL) for presbyopia correction. Setting: Multicenter study at 7 sites. Design: Nonrandomized prospective clinical trial. Methods: Presbyopic patients without cataracts undergoing bilateral multifocal pIOL implantation (Ophtec ArtiPlus) were studied. The primary outcome for efficacy was the visual acuity at distance, intermediate, and near. Secondary outcomes included endothelial cell density (ECD), postoperative refraction, binocular defocus curve, vision quality, spectacle independence, and patient satisfaction. Results: 49 subjects (98 eyes) were included. At 6 months, the mean binocular uncorrected distance intermediate, and near visual acuity was −0.05 ± 0.09 logMAR, −0.02 ± 0.07 logMAR, and 0.02 ± 0.08 logMAR, respectively. The ECD remained stable with a mean value of 2771 ± 289 cells/mm 2 at 6 months postoperatively. The mean spherical equivalent was −0.42 ± 0.33 diopters (D), with 95% eyes having a prediction error within ±1.0 D and 77% within ±0.5 D. The binocular distance-corrected defocus curve showed a visual acuity of 0.20 logMAR or better over a range of +1.0 to −3.5 D. Patient satisfaction was high, with a mean score of 3.5 on a 4-point scale, and 83% of the patients reported spectacle independence. 47%, 35%, and 96% of patients reported experiencing glare, halos, and starbursts at well-tolerated levels, respectively. Notably, only 2% of patients found halos and starbursts to be very bothersome. Conclusions: Bilateral ArtiPlus multifocal pIOL implantation demonstrated good visual acuity from distant to near and maintained stable ECD over 6 months. Patients reported high levels of satisfaction and spectacle independence, despite some optical disturbances.
- 1 November 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (11) , 963-971
Open AccessSix-month performance and safety of an iris-fixated multifocal intraocular lens for presbyopia correction in phakic eyes
Purpose: To evaluate the 6-month effectiveness and safety of a new foldable multifocal iris-fixated phakic intraocular lens (pIOL) for presbyopia correction. Setting: Multicenter study at 7 sites. Design: Nonrandomized prospective clinical trial. Methods: Presbyopic patients without cataracts undergoing bilateral multifocal pIOL implantation (Ophtec ArtiPlus) were studied. The primary outcome for efficacy was the visual acuity at distance, intermediate, and near. Secondary outcomes included endothelial cell density (ECD), postoperative refraction, binocular defocus curve, vision quality, spectacle independence, and patient satisfaction. Results: 49 subjects (98 eyes) were included. At 6 months, the mean binocular uncorrected distance intermediate, and near visual acuity was −0.05 ± 0.09 logMAR, −0.02 ± 0.07 logMAR, and 0.02 ± 0.08 logMAR, respectively. The ECD remained stable with a mean value of 2771 ± 289 cells/mm 2 at 6 months postoperatively. The mean spherical equivalent was −0.42 ± 0.33 diopters (D), with 95% eyes having a prediction error within ±1.0 D and 77% within ±0.5 D. The binocular distance-corrected defocus curve showed a visual acuity of 0.20 logMAR or better over a range of +1.0 to −3.5 D. Patient satisfaction was high, with a mean score of 3.5 on a 4-point scale, and 83% of the patients reported spectacle independence. 47%, 35%, and 96% of patients reported experiencing glare, halos, and starbursts at well-tolerated levels, respectively. Notably, only 2% of patients found halos and starbursts to be very bothersome. Conclusions: Bilateral ArtiPlus multifocal pIOL implantation demonstrated good visual acuity from distant to near and maintained stable ECD over 6 months. Patients reported high levels of satisfaction and spectacle independence, despite some optical disturbances.
- Open Access
- 16 October 2025
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 263 (12) , 3423-3432
Association of intraocular lens tilt and decentration with visual acuity using SS-OCT-based analysis
Purpose: To evaluate the association of postoperative IOL tilt and decentration and corrected distance visual acuity (CDVA) by performing analyses using IOLMaster700 data and custom-developed software. Setting: University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands. Methods: This case series included patients after cataract surgery who underwent SS-OCT scans using the IOLMaster700 with custom-developed software for tilt and decentration analyses. The outcomes based on our custom-developed software were conducted along the pupillary axis (PA) and corneal topographic axis (CTA). Associations between tilt, decentration and CDVA were evaluated. Results: A total of 168 eyes (168 patients) were analyzed. The maximum observed IOL tilt was 9.54° along the CTA and 3.69° along the PA. Maximum decentration reached 2.22 mm (CTA) and 2.17 mm (PA). Mean tilt was 1.21 ± 0.69° (PA) and 4.87 ± 1.52° (CTA), while mean decentration was 0.27 ± 0.25 mm (PA) and 0.27 ± 0.26 mm (CTA). Regression analyses showed no statistically significant associations between tilt or decentration and CDVA, irrespective of the reference axis used. For tilt along the PA, the regression coefficient (B) was 0.004 (95%CI -0.011, 0.020; P = 0.592), for tilt along the CTA, B was − 0.006 (95%CI -0.013, 0.001; P = 0.082). For decentration, B was 0.012 (95%CI -0.020, 0.044; P = 0.455) and 0.002 (SE = 0.018, 95%CI -0.034, 0.037; P = 0.925) along the PA and CTA, respectively. Conclusion: In this cohort, IOL tilt and decentration were generally small, with no detectable association with CDVA. The findings emphasize that different assessment methods should not be used interchangeably, and potential effects cannot be excluded given the limited sample and range of values.
- 16 October 2025
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 263 (12) , 3423-3432
Open AccessAssociation of intraocular lens tilt and decentration with visual acuity using SS-OCT-based analysis
Purpose: To evaluate the association of postoperative IOL tilt and decentration and corrected distance visual acuity (CDVA) by performing analyses using IOLMaster700 data and custom-developed software. Setting: University Eye Clinic Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands. Methods: This case series included patients after cataract surgery who underwent SS-OCT scans using the IOLMaster700 with custom-developed software for tilt and decentration analyses. The outcomes based on our custom-developed software were conducted along the pupillary axis (PA) and corneal topographic axis (CTA). Associations between tilt, decentration and CDVA were evaluated. Results: A total of 168 eyes (168 patients) were analyzed. The maximum observed IOL tilt was 9.54° along the CTA and 3.69° along the PA. Maximum decentration reached 2.22 mm (CTA) and 2.17 mm (PA). Mean tilt was 1.21 ± 0.69° (PA) and 4.87 ± 1.52° (CTA), while mean decentration was 0.27 ± 0.25 mm (PA) and 0.27 ± 0.26 mm (CTA). Regression analyses showed no statistically significant associations between tilt or decentration and CDVA, irrespective of the reference axis used. For tilt along the PA, the regression coefficient (B) was 0.004 (95%CI -0.011, 0.020; P = 0.592), for tilt along the CTA, B was − 0.006 (95%CI -0.013, 0.001; P = 0.082). For decentration, B was 0.012 (95%CI -0.020, 0.044; P = 0.455) and 0.002 (SE = 0.018, 95%CI -0.034, 0.037; P = 0.925) along the PA and CTA, respectively. Conclusion: In this cohort, IOL tilt and decentration were generally small, with no detectable association with CDVA. The findings emphasize that different assessment methods should not be used interchangeably, and potential effects cannot be excluded given the limited sample and range of values.
- Open Access
- 18 August 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e72574
Optimizing the Postcataract Patient Journey Using AI-Driven Teleconsultation: Prospective Case Study
Background: Given the increasing global demand for ophthalmologic care and the anticipated shortage of ophthalmology professionals, innovative solutions are essential for optimizing health care delivery. Digital health technologies offer promising opportunities to efficiently manage high patient volumes. Cataract surgery, with its established safety profile and routine postoperative care, provides an ideal setting for implementing such innovations. Structured clinical questions have proven effective in identifying patients requiring further assessment, supporting the feasibility of follow-up through telephone consultations. To further extend this approach, artificial intelligence–based follow-up systems may offer an opportunity to automate these interactions, reduce clinician workload, and streamline care pathways. Objective: The aim of the study is to assess the clinical safety and effectiveness of an artificial intelligence–based follow-up call system (Dora-NL1) in identifying patients who require further assessment after cataract surgery in the Netherlands. Methods: This prospective single-center study was conducted at the University Eye Clinic Maastricht, the Netherlands. Adult patients who underwent uncomplicated cataract surgery were eligible to participate. All patients received a Dora-NL1 follow-up telephone call at 1 and 4 weeks postoperatively in addition to standard care (a clinician-led telephone consultation at week 1 and an in-person hospital visit at week 4). The Dora-NL1 calls used a standard conversational flow to evaluate symptoms and recommend a clinical outcome. The recommended outcomes of Dora-NL1 were based on the symptoms reported by the patient. Clinical safety and accuracy were assessed by comparing Dora-NL1 outcomes to blinded clinician assessments of recorded calls and to standard postoperative care. Patient-reported usability was measured using the Telehealth Usability Questionnaire and Net Promoter Score. Results: A total of 105 patients with a mean age of 72 (SD 7) years were included in the analysis. Dora-NL1 demonstrated high agreement with clinician-supervised calls, with symptom evaluation accuracy ranging from 89% to 99% (κ=0.390‐0.947) and care management decision accuracy between 83% and 88% (κ=0.640‐0.753). At week 1, Dora-NL1 showed a sensitivity of 100% and a specificity of 42% compared to standard clinician-led telephone consultations with no missed clinical concerns. At week 4, compared to the in-person follow-up, Dora-NL1 failed to identify 4 (4.1%) patients who required unexpected management changes, including 3 with asymptomatic complications detected only via slit lamp examination and 1 with complaints in the nonoperated eye. Patients rated Dora-NL1 positively, with Net Promoter Scores of +13.5 and +12.6 at week 1 and 4, respectively. The Telehealth Usability Questionnaire was completed by 98 patients, yielding a mean score of 3.19 (SD 1.13) on a 5-point scale, highlighting its simplicity, ease of use, and audibility. Conclusions: Dora-NL1 is a safe and effective tool for automated postoperative screening following cataract surgery. It offers a safe alternative to clinician-led telephone consultations in routine cases but cannot fully replace in-person examinations.
- 18 August 2025
- Published by JMIR Publications Inc. in JMIR Formative Research
- Vol. 9, e72574
Open AccessOptimizing the Postcataract Patient Journey Using AI-Driven Teleconsultation: Prospective Case Study
Background: Given the increasing global demand for ophthalmologic care and the anticipated shortage of ophthalmology professionals, innovative solutions are essential for optimizing health care delivery. Digital health technologies offer promising opportunities to efficiently manage high patient volumes. Cataract surgery, with its established safety profile and routine postoperative care, provides an ideal setting for implementing such innovations. Structured clinical questions have proven effective in identifying patients requiring further assessment, supporting the feasibility of follow-up through telephone consultations. To further extend this approach, artificial intelligence–based follow-up systems may offer an opportunity to automate these interactions, reduce clinician workload, and streamline care pathways. Objective: The aim of the study is to assess the clinical safety and effectiveness of an artificial intelligence–based follow-up call system (Dora-NL1) in identifying patients who require further assessment after cataract surgery in the Netherlands. Methods: This prospective single-center study was conducted at the University Eye Clinic Maastricht, the Netherlands. Adult patients who underwent uncomplicated cataract surgery were eligible to participate. All patients received a Dora-NL1 follow-up telephone call at 1 and 4 weeks postoperatively in addition to standard care (a clinician-led telephone consultation at week 1 and an in-person hospital visit at week 4). The Dora-NL1 calls used a standard conversational flow to evaluate symptoms and recommend a clinical outcome. The recommended outcomes of Dora-NL1 were based on the symptoms reported by the patient. Clinical safety and accuracy were assessed by comparing Dora-NL1 outcomes to blinded clinician assessments of recorded calls and to standard postoperative care. Patient-reported usability was measured using the Telehealth Usability Questionnaire and Net Promoter Score. Results: A total of 105 patients with a mean age of 72 (SD 7) years were included in the analysis. Dora-NL1 demonstrated high agreement with clinician-supervised calls, with symptom evaluation accuracy ranging from 89% to 99% (κ=0.390‐0.947) and care management decision accuracy between 83% and 88% (κ=0.640‐0.753). At week 1, Dora-NL1 showed a sensitivity of 100% and a specificity of 42% compared to standard clinician-led telephone consultations with no missed clinical concerns. At week 4, compared to the in-person follow-up, Dora-NL1 failed to identify 4 (4.1%) patients who required unexpected management changes, including 3 with asymptomatic complications detected only via slit lamp examination and 1 with complaints in the nonoperated eye. Patients rated Dora-NL1 positively, with Net Promoter Scores of +13.5 and +12.6 at week 1 and 4, respectively. The Telehealth Usability Questionnaire was completed by 98 patients, yielding a mean score of 3.19 (SD 1.13) on a 5-point scale, highlighting its simplicity, ease of use, and audibility. Conclusions: Dora-NL1 is a safe and effective tool for automated postoperative screening following cataract surgery. It offers a safe alternative to clinician-led telephone consultations in routine cases but cannot fully replace in-person examinations.
- Open Access
- 1 August 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (8) , 731-739
Efficacy of remote care in cataract surgery: systematic review
Topic: To evaluate the efficacy of currently available digital and remote care applications for postoperative cataract management compared with traditional methods for postoperative clinical measurements. Clinical Relevance: With the increasing demand for ophthalmological services and an anticipated shortage of professionals, innovative approaches are needed to optimize care. Cataract surgery, characterized by its high-safety profile and turnover rate, is well-suited for digital and remote care solutions, which could enhance the postoperative patient pathway, potentially leading to substantial time and cost savings. Methods: A systematic search was performed in Ovid Embase, Ovid MEDLINE, KSR Evidence, CINAHL, and Cochrane CENTRAL Library for randomized controlled trials (RCTs) and observational studies on digital tools, telemedicine, or remote care in postoperative cataract management. Reported outcomes included patient-reported outcomes, visual acuity, refraction, intraocular pressure, slitlamp and fundus examination, or complication prevalence. The risk of bias was evaluated using the Cochrane Risk-of-Bias Assessment Tool (v. 2) and Joanna Briggs Institute Critical appraisal checklists. Data extraction included both qualitative and quantitative information. The protocol was registered at International Prospective Register of Systematic Reviews (CRD42024505933). Results: The search identified 11 319 studies of which 14 were included. These comprised 4 RCTs and 10 observational studies involving 2681 patients. Interventions were categorized into telephone consultation, messaging, automated phone calls, and mobile applications/software. Telephone consultations were effective for follow-up screening, and automated phone calls also showed promising results. Messaging was suggested to improve adherence in the early postoperative period. Visual acuity assessment tools showed potential as screening methods, but exhibited variability compared with conventional methods and had wide 95% limits of agreement. All types of interventions were well-accepted by patients. Conclusions: Early evidence supports a positive impact of implementing digital and remote care tools in the postoperative cataract management pathway, particularly for screening purposes. However, further research is needed to define their roles and develop clinical practice guidelines.
- 1 August 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (8) , 731-739
Open AccessEfficacy of remote care in cataract surgery: systematic review
Topic: To evaluate the efficacy of currently available digital and remote care applications for postoperative cataract management compared with traditional methods for postoperative clinical measurements. Clinical Relevance: With the increasing demand for ophthalmological services and an anticipated shortage of professionals, innovative approaches are needed to optimize care. Cataract surgery, characterized by its high-safety profile and turnover rate, is well-suited for digital and remote care solutions, which could enhance the postoperative patient pathway, potentially leading to substantial time and cost savings. Methods: A systematic search was performed in Ovid Embase, Ovid MEDLINE, KSR Evidence, CINAHL, and Cochrane CENTRAL Library for randomized controlled trials (RCTs) and observational studies on digital tools, telemedicine, or remote care in postoperative cataract management. Reported outcomes included patient-reported outcomes, visual acuity, refraction, intraocular pressure, slitlamp and fundus examination, or complication prevalence. The risk of bias was evaluated using the Cochrane Risk-of-Bias Assessment Tool (v. 2) and Joanna Briggs Institute Critical appraisal checklists. Data extraction included both qualitative and quantitative information. The protocol was registered at International Prospective Register of Systematic Reviews (CRD42024505933). Results: The search identified 11 319 studies of which 14 were included. These comprised 4 RCTs and 10 observational studies involving 2681 patients. Interventions were categorized into telephone consultation, messaging, automated phone calls, and mobile applications/software. Telephone consultations were effective for follow-up screening, and automated phone calls also showed promising results. Messaging was suggested to improve adherence in the early postoperative period. Visual acuity assessment tools showed potential as screening methods, but exhibited variability compared with conventional methods and had wide 95% limits of agreement. All types of interventions were well-accepted by patients. Conclusions: Early evidence supports a positive impact of implementing digital and remote care tools in the postoperative cataract management pathway, particularly for screening purposes. However, further research is needed to define their roles and develop clinical practice guidelines.
- Open Access
- 1 May 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (5) , 399-405
Dissatisfaction after implantation of EDOF intraocular lenses
Purpose: To evaluate the symptoms, etiology, and treatment of patient dissatisfaction after extended depth-of-focus (EDOF) intraocular lens (IOL) implantation. Setting: University Eye Clinic, Maastricht University Medical Center, the Netherlands. Design: Retrospective case series. Methods: For this study, all medical records of patients who received an EDOF IOL from July 2020 to July 2022 were reviewed. Patients were included if they had reported any dissatisfaction after surgery. The main outcome parameters were reasons for dissatisfaction (subjective complaints) and the presumed etiology of the complaints. Results: Of 202 patients (354 eyes) who underwent EDOF IOL implantation, 83 eyes (22.8%) of 52 dissatisfied patients were included. Blurred vision was the predominant complaint, reported in 78 eyes (94%). Photic phenomena were reported in 21 eyes (25.3%), with 16 eyes (76.2%) experiencing coexisting blurred vision. The major etiologies for dissatisfaction in this cohort were residual ametropia (51.8%), dry eye disease (26.5%), and posterior capsular opacification (12.0%). Treatments were administered to 85.5% of the eyes, including interventions such as artificial tears, spectacles, or refractive surgery enhancement. A small number of patients (n = 12; 5.9%) remained dissatisfied despite intervention. Conclusions: Based on this real-world data study, dissatisfaction after EDOF IOL implantation can be effectively identified and treated in most cases.
- 1 May 2025
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 51 (5) , 399-405
Open AccessDissatisfaction after implantation of EDOF intraocular lenses
Purpose: To evaluate the symptoms, etiology, and treatment of patient dissatisfaction after extended depth-of-focus (EDOF) intraocular lens (IOL) implantation. Setting: University Eye Clinic, Maastricht University Medical Center, the Netherlands. Design: Retrospective case series. Methods: For this study, all medical records of patients who received an EDOF IOL from July 2020 to July 2022 were reviewed. Patients were included if they had reported any dissatisfaction after surgery. The main outcome parameters were reasons for dissatisfaction (subjective complaints) and the presumed etiology of the complaints. Results: Of 202 patients (354 eyes) who underwent EDOF IOL implantation, 83 eyes (22.8%) of 52 dissatisfied patients were included. Blurred vision was the predominant complaint, reported in 78 eyes (94%). Photic phenomena were reported in 21 eyes (25.3%), with 16 eyes (76.2%) experiencing coexisting blurred vision. The major etiologies for dissatisfaction in this cohort were residual ametropia (51.8%), dry eye disease (26.5%), and posterior capsular opacification (12.0%). Treatments were administered to 85.5% of the eyes, including interventions such as artificial tears, spectacles, or refractive surgery enhancement. A small number of patients (n = 12; 5.9%) remained dissatisfied despite intervention. Conclusions: Based on this real-world data study, dissatisfaction after EDOF IOL implantation can be effectively identified and treated in most cases.
- Open Access
- 24 April 2025
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 276, 286-296
Two novel extended depth-of-focus intraocular lenses targeted for mini-monovision: A prospective randomized controlled trial
- 24 April 2025
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 276, 286-296
Open AccessTwo novel extended depth-of-focus intraocular lenses targeted for mini-monovision: A prospective randomized controlled trial
- Open Access
- 24 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Optimizing the post-cataract patient journey using artificial intelligence-driven teleconsultation: a prospective case study. (Preprint)
BACKGROUND Given the increasing global demand for ophthalmologic care and the anticipated shortage of ophthalmology professionals, innovative solutions are essential for optimizing healthcare delivery. Digital health technologies offer promising opportunities to efficiently manage high patient volumes. Cataract surgery, with its established safety profile and routine postoperative care, is provides an ideal setting for these innovations. Structured clinical questions can effectively identify patients requiring further assessment, enabling clinicians to screen for complications through telephone consultations. Moreover, an artificial intelligence-based follow-up system could take this a step further by automating the process, reducing the need for clinician involvement while enabling more efficient postoperative screening for complications. OBJECTIVE To assess the clinical safety and effectiveness of an artificial intelligence-based follow-up call system (Dora-NL1) in identifying patients who require further assessment after cataract surgery in the Netherlands. METHODS Patients who underwent uncomplicated cataract surgery were eligible to participate. All patients received a Dora-NL1 follow-up call at 1 and 4 weeks postoperatively, in addition to routine postoperative cataract care. Dora-NL1 evaluated postoperative symptoms and made suggestions for care management decisions. The Dora-NL1 outcomes were compared with clinician assessments of recorded Dora-NL1 calls and regular care. User-acceptability was evaluated using the Telehealth Usability Questionnaire (TUQ). RESULTS A total of 105 patients were included in the analysis. Dora-NL1 demonstrated high accuracy compared to clinician-supervised calls, with symptom evaluation accuracy of 89% to 99% and care management decision accuracy of 83% to 88%. At week 1, the sensitivity and specificity compared to standard telephone consultations were 100% and 42%, with no clinical concerns missed. However, at post-operative week 4, compared to an in-person hospital visit, Dora-NL1 did not identify unexpected management changes in 4 patients (4.1%). All 4 of these patients had issues that were only detected after slit lamp examination, reflecting the system’s reliance on patient reported symptoms. Patients rated Dora-NL1 positively, with a mean TUQ score of 3/5, highlighting its simplicity, ease of use, and audibility. CONCLUSIONS Dora-NL1 is a safe and effective screening tool for postoperative cataract surgery, offering a safe alternative to telephone consultations, but this cannot fully replace in-person examinations. CLINICALTRIAL Not applicable.
- 24 February 2025
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessOptimizing the post-cataract patient journey using artificial intelligence-driven teleconsultation: a prospective case study. (Preprint)
BACKGROUND Given the increasing global demand for ophthalmologic care and the anticipated shortage of ophthalmology professionals, innovative solutions are essential for optimizing healthcare delivery. Digital health technologies offer promising opportunities to efficiently manage high patient volumes. Cataract surgery, with its established safety profile and routine postoperative care, is provides an ideal setting for these innovations. Structured clinical questions can effectively identify patients requiring further assessment, enabling clinicians to screen for complications through telephone consultations. Moreover, an artificial intelligence-based follow-up system could take this a step further by automating the process, reducing the need for clinician involvement while enabling more efficient postoperative screening for complications. OBJECTIVE To assess the clinical safety and effectiveness of an artificial intelligence-based follow-up call system (Dora-NL1) in identifying patients who require further assessment after cataract surgery in the Netherlands. METHODS Patients who underwent uncomplicated cataract surgery were eligible to participate. All patients received a Dora-NL1 follow-up call at 1 and 4 weeks postoperatively, in addition to routine postoperative cataract care. Dora-NL1 evaluated postoperative symptoms and made suggestions for care management decisions. The Dora-NL1 outcomes were compared with clinician assessments of recorded Dora-NL1 calls and regular care. User-acceptability was evaluated using the Telehealth Usability Questionnaire (TUQ). RESULTS A total of 105 patients were included in the analysis. Dora-NL1 demonstrated high accuracy compared to clinician-supervised calls, with symptom evaluation accuracy of 89% to 99% and care management decision accuracy of 83% to 88%. At week 1, the sensitivity and specificity compared to standard telephone consultations were 100% and 42%, with no clinical concerns missed. However, at post-operative week 4, compared to an in-person hospital visit, Dora-NL1 did not identify unexpected management changes in 4 patients (4.1%). All 4 of these patients had issues that were only detected after slit lamp examination, reflecting the system’s reliance on patient reported symptoms. Patients rated Dora-NL1 positively, with a mean TUQ score of 3/5, highlighting its simplicity, ease of use, and audibility. CONCLUSIONS Dora-NL1 is a safe and effective screening tool for postoperative cataract surgery, offering a safe alternative to telephone consultations, but this cannot fully replace in-person examinations. CLINICALTRIAL Not applicable.
- Open Access
- 1 September 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (9) , 947-955
Web-based telemonitoring of visual function and self-reported postoperative outcomes in cataract care: international multicenter randomized controlled trial
Purpose: To compare web-based, self-administered follow-up after cataract surgery to conventional face-to-face follow-up. Setting: Eye clinics in the Netherlands, Austria, and Germany. Design: Randomized controlled trial with an embedded method comparison study (ClinicalTrials.gov: NCT04809402). Methods: Routine patients with cataract were randomized into 2 groups: The telemonitoring group undertook web-based vision self-assessments and questionnaires from home, while the usual care group received conventional care. All participants had a 4- to 6-week postoperative clinic visit for safety and validation purposes. Outcomes included, the web test's accuracy for assessing postoperative visual acuity (VA) and refractive error, adverse event rates, and patient-reported outcome measurements (PROMs). Results: 94 participants (188 eyes) were enrolled. Web-based uncorrected distance VA testing demonstrated a negligible mean difference (−0.03 ± 0.14 logMAR) when compared with conventional Early Treatment Diabetic Retinopathy Study chart testing, with 95% limits of agreement ranging from −0.30 to 0.24 logMAR. The web-based refraction assessment overestimated the postoperative refractive error (mean difference in spherical equivalent 0.15 ± 0.67 diopters), resulting in a poorer corrected distance VA compared with subjective refraction (mean 0.1 vs −0.1 logMAR). Rates of adverse events and unscheduled consultations were minimal across both groups. Preoperative and postoperative PROM questionnaires had a 100% response rate. Visual functioning (Catquest-9SF and National Eye Institute Visual Function Questionnaire-25) improved postoperatively (mean improvement −0.80 and 16.70, respectively) and did not significantly differ between the 2 groups. Conclusions: The patients with cataract in this study effectively provided postoperative outcome data using a web interface. Both conventional and web-based follow-ups yielded similar PROMs and adverse event rates. Future developments should reduce the variability in the web-based VA test and yield representative refraction outcomes.
- 1 September 2024
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 50 (9) , 947-955
Open AccessWeb-based telemonitoring of visual function and self-reported postoperative outcomes in cataract care: international multicenter randomized controlled trial
Purpose: To compare web-based, self-administered follow-up after cataract surgery to conventional face-to-face follow-up. Setting: Eye clinics in the Netherlands, Austria, and Germany. Design: Randomized controlled trial with an embedded method comparison study (ClinicalTrials.gov: NCT04809402). Methods: Routine patients with cataract were randomized into 2 groups: The telemonitoring group undertook web-based vision self-assessments and questionnaires from home, while the usual care group received conventional care. All participants had a 4- to 6-week postoperative clinic visit for safety and validation purposes. Outcomes included, the web test's accuracy for assessing postoperative visual acuity (VA) and refractive error, adverse event rates, and patient-reported outcome measurements (PROMs). Results: 94 participants (188 eyes) were enrolled. Web-based uncorrected distance VA testing demonstrated a negligible mean difference (−0.03 ± 0.14 logMAR) when compared with conventional Early Treatment Diabetic Retinopathy Study chart testing, with 95% limits of agreement ranging from −0.30 to 0.24 logMAR. The web-based refraction assessment overestimated the postoperative refractive error (mean difference in spherical equivalent 0.15 ± 0.67 diopters), resulting in a poorer corrected distance VA compared with subjective refraction (mean 0.1 vs −0.1 logMAR). Rates of adverse events and unscheduled consultations were minimal across both groups. Preoperative and postoperative PROM questionnaires had a 100% response rate. Visual functioning (Catquest-9SF and National Eye Institute Visual Function Questionnaire-25) improved postoperatively (mean improvement −0.80 and 16.70, respectively) and did not significantly differ between the 2 groups. Conclusions: The patients with cataract in this study effectively provided postoperative outcome data using a web interface. Both conventional and web-based follow-ups yielded similar PROMs and adverse event rates. Future developments should reduce the variability in the web-based VA test and yield representative refraction outcomes.